About Adviteeya Pharma
Adviteeya Pharma is a company based in Hyderabad (India) founded in 2016. It operates as a B2B. The company has 3 employees. Adviteeya Pharma offers products and services including Key Starting Materials and API Intermediates. Adviteeya Pharma operates in a competitive market with competitors including WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
- Headquarter Hyderabad, India
- Employees 3
- SectorsHealthcareChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website adviteeyapharma.com
- Legal Name Adviteeya Pharma Private Limited
- Date of Incorporation 25 Apr, 2016
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹8.98 Cr
FY 2022 · +76% YoY
- Net Profit₹9.3 Lakh
FY 2022 · 1% margin
- EBITDA-₹20.8 Lakh
FY 2022 · -2% margin
- Employee Count3
Associated legal entities of Adviteeya Pharma
Adviteeya Pharma operates through Adviteeya Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Adviteeya Pharma Private Limited CIN U24299TG2016PTC109191 | Active | 25 Apr 2016 | Hyderabad, Telangana | ₹9.0 Cr | 3 | 2 | View details |
Products & Services of Adviteeya Pharma
Adviteeya Pharma offers a comprehensive portfolio of products and services, including Key Starting Materials and API Intermediates.
Essential compounds for pharmaceutical API synthesis and production.
Chemical compounds used in active pharmaceutical ingredient manufacturing.
Board of directors of Adviteeya Pharma Private Limited (Adviteeya Pharma)
Adviteeya Pharma Private Limited is the primary company behind Adviteeya Pharma. The board of Adviteeya Pharma Private Limited currently have 2 directors; the longest-serving is Usha Damera, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Usha Damera DIN 07483708 | Managing Director | 25 Apr 2016 | 10 yrs 5 mo | Adviteeya Pharma Private Limited |
| Prasad Mallisetty DIN 07463412 | Director | 25 Apr 2016 | 10 yrs 5 mo | Adviteeya Pharma Private Limited |
Financials of Adviteeya Pharma
Figures of Adviteeya Pharma Private Limited, the primary company behind Adviteeya Pharma, for FY 2022. Revenue was ₹8.98 Cr (+76% year on year). Net profit was ₹9.3 Lakh (1% margin). EBITDA was -₹20.8 Lakh (-2% margin). Revenue has grown at a compounded annual rate of +42% over three years and +127% over five years.
- ₹8.98 CrRevenue · FY 2022 · +76% YoY
- ₹9.3 LakhNet profit · 1% margin
- -₹20.8 LakhEBITDA · -2% margin
- ₹1 LakhPaid-up capital
- 3Employees (provident fund records)
- +42%Revenue CAGR, 3 years
- +127%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Adviteeya Pharma Private Limited are on its company page.
Detailed financial statements for Adviteeya Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Adviteeya Pharma
Adviteeya Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as WuXi AppTec, Eurofins Scientific, Ipsen, ANI Pharmaceuticals and Red Nucleus, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| wuxiapptec.com | 2000 | Shanghai, China | $40M | 1,681 | Provider of CRO and CDMO services | |
| eurofins.com | 1987 | Luxembourg | – | – | Laboratory testing and contract research services are provided globally. | |
| ipsen.com | 1929 | – | – | 505 | Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes | |
| anipharmaceuticals.com | 1996 | Baudette, United States | – | 600 | Branded and generic prescription drugs are developed, manufactured, and marketed. | |
| rednucleus.com | 2014 | Yardley, United States | – | 176 | Advisory, scientific, and medical communications provided for pharmaceutical industry. | |
| aptar.com | 1992 | Crystal Lake, United States | – | 232 | Regulatory support, brand differentiation, and prototyping services are provided. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| aliadatx.com | 2021 | Boston, United States | $33M | – | Provider of drug research & development services for multiple therapeutic areas | |
| cms.net.cn | 1992 | Shenzhen, China | – | – | Generic formulations including tablets, capsules, liquids, and injectables are manufactured. |
Detailed competitors of Adviteeya Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Adviteeya Pharma
10 companies that operate in the same segment as Adviteeya Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Adviteeya Pharma
Adviteeya Pharma was founded in 2016.
Adviteeya Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Adviteeya Pharma has 3 employees.
The primary company behind Adviteeya Pharma, Adviteeya Pharma Private Limited, reported revenue of ₹8.98 Cr for FY 2022, up 76% year on year.
Adviteeya Pharma, incorporated in 2016, specializes in manufacturing Key Starting Materials and API Intermediates for the pharmaceutical industry. The company operates from Hyderabad, Telangana, India, focusing on high-quality production with an emphasis on eco-friendly practices and competitive pricing. It aims to supply reliable intermediates to other firms, ensuring consistency and customer satisfaction through scheduled deliveries and quality control.
Adviteeya Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Adviteeya Pharma offers Key Starting Materials and API Intermediates.
Adviteeya Pharma operates through Adviteeya Pharma Private Limited.
The legal entities of Adviteeya Pharma currently have 2 directors, including Usha Damera, Prasad Mallisetty.